trending Market Intelligence /marketintelligence/en/news-insights/trending/ylkfg_qxg1-fmydjvg7zya2 content esgSubNav
In This List

Oryzon Genomics adds Synlogic CEO to board

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


Oryzon Genomics adds Synlogic CEO to board

Barcelona, Spain-based Oryzon Genomics SA added José Gutiérrez-Ramos to the company's board as an independent director.

Gutiérrez-Ramos is the president and CEO of Synlogic Inc.

Meanwhile, three directors representing Najeti, a private investment fund that owns 20.54% of Oryzon's capital, have resigned from the company's board.

Following the changes, Oryzon's board is now composed of seven directors, with four as independent directors.

Oryzon develops therapies for cancer and neurodegenerative diseases.